DR. RANDY DEAN WALKER MD NPI 1730185752

NPI Details

DR. Randy Dean Walker, MD is a family medicine in De Queen, AR with 26 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Randy Dean Walker, MD NPI is 1730185752. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Graduation Year:2000

The provider's business location address is:

1553 W COLLIN RAYE DR
DE QUEEN, AR
ZIP 71832-801
Phone: (870) 584-3000
Fax: (870) 584-3003

The NPI 1730185752 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 04D1013224 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Professional service for preparation and provision of 1 or more antigens (HCPCS:95165)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Professional service for single injection of allergen (HCPCS:95115)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Urinalysis, manual test (HCPCS:81002)
• Hemoglobin a1c level (HCPCS:83036)
• X-ray of chest, 2 views (HCPCS:71046)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Blood test, clotting time (HCPCS:85610)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow (HCPCS:G0181)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Creatine kinase (cardiac enzyme) level, mb fraction only (HCPCS:82553)
• Myoglobin (muscle protein) level (HCPCS:83874)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Red blood cell concentration measurement (HCPCS:85014)
• Blood count, hemoglobin (HCPCS:85018)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Removal of impacted ear wax (HCPCS:69210)
• Blood glucose (sugar) level (HCPCS:82947)
• Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
• Follow-up nursing facility visit per day, typically 35 minutes (HCPCS:99310)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of hip, 2-3 views (HCPCS:73502)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Administration of vaccine (HCPCS:90471)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Test for detection of infectious agent antibody, qualitative or semiquantitative (HCPCS:86318)
• Photography of the retina (HCPCS:92250)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• X-ray of upper spine, 2-3 views (HCPCS:72040)
• Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
• X-ray of abdomen, 1 view (HCPCS:74018)
• X-ray of knee, 3 views (HCPCS:73562)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Administration of vaccine, each additional vaccine (HCPCS:90472)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• X-ray of chest, 1 view (HCPCS:71045)
• Ringers lactate infusion, up to 1000 cc (HCPCS:J7120)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Established patient home visit, typically 40 minutes (HCPCS:99349)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/23/2005 and was last updated on 1/11/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.